Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Imbrium Therapeutics and TetraGenetics Announce Strategic Research Collaboration and License Option to Develop Novel Biologic Therapeutics
Wednesday, February 27, 2019Imbrium Therapeutics LP a clinicalstage biopharmaceutical company and operating subsidiary of Purdue Pharma LP and TetraGenetics Inc a biotech company developing novel therapeutics for pain indications and autoimmune diseases today announced a strate...
Selexis SA and Turgut Pharmaceuticals Expand Biosimilar Development Relationship by Signing Two Commercial License Agreements
Wednesday, February 27, 2019Selexis SA and Turgut Pharmaceuticals Turgut Ilaclari AS announced today that they have signed two commercial license agreements CLAs through which Turgut will leverage Selexis SUREtechnology Platform and SURE CHOM Cell Line for the development of tw...
Mallinckrodt announces collaboration agreement of extracorporeal photoapheresis (FEC) with Transimmune AG
Tuesday, February 26, 2019Mallinckrodt plc the worlds leading pharmaceutical specialty company today announced that it has signed a research collaboration agreement with Transimmune AG a company that develops novel immunotherapies based on its unique understanding of the phys...
Titan Pharmaceuticals Partners With AllianceRx Walgreens Prime Specialty Pharmacy To Expand Patient Access To Probuphine®
Tuesday, February 26, 2019Titan Pharmaceuticals Inc today announced the execution of a specialty pharmacy distribution and services agreement with AllianceRx Walgreens Prime that will expand patient access to treatment with Probuphine buprenorphine implant Titans unique sixmo...
AbbVie and Voyager Therapeutics Announce Collaboration to Develop Vectorized Antibodies to Treat Parkinson's Disease
Monday, February 25, 2019AbbVie a global biopharmaceutical company and Voyager Therapeutics Inc a clinicalstage gene therapy company focused on developing lifechanging treatments for severe neurological diseases today announced an exclusive global strategic collaboration and...
Torque Announces Clinical Trial Collaboration with Merck
Friday, February 22, 2019Torque a clinicalstage immunooncology company developing firstinclass Deep Primed T Cell Therapeutics to direct immune power deep within the tumor microenvironment announced today that it has entered into a clinical trial collaboration agreement with...
Morphic Therapeutic Enters Into Integrin Research and Development Collaboration with Janssen
Friday, February 22, 2019Morphic Therapeutic Morphic a biotechnology company developing oral integrin therapies announced today that it has entered into a research and development collaboration with Janssen Biotech Inc Janssen to discover and develop novel integrin therapeut...
NanoSphere Signs Definitive Licensing Agreement in Oregon
Thursday, February 21, 2019NanoSphere Health Sciences Inc is pleased to announce the signing of a definitive Licensing Agreement with Oregon cannabis company Cascade Pure LLC The Agreement gives Cascade Pure the exclusive right to produce and distribute Evolve Formulas product...
Adial Pharmaceuticals Announces Partnership with Catalent to Package and Distribute Adial’s AD04 for its Phase 3 Trial
Thursday, February 21, 2019Adial Pharmaceuticals Inc wwwadialpharmacom a clinicalstage biopharmaceutical company focused on the development of medicines for addiction today announced a partnership with Catalent Pharma Solutions a leading global provider of advanced delivery te...
Exicure Announces License and Development Agreement with Dermelix Biotherapeutics in Rare Genetic Skin Diseases
Wednesday, February 20, 2019Exicure Inc OTCQB XCUR the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid SNA constructs and Dermelix Biotherapeutics a biopharmaceutical company focused on the development of innovative treatments for rare ge...
